Department of Pharmacy, AdventHealth Orlando, Orlando, Florida, USA
Department of Pharmacy, Baptist Health, Jacksonville, Florida, USA.
BMJ Open Respir Res. 2020 Apr;7(1). doi: 10.1136/bmjresp-2020-000572.
A low-cost, quantitative method to evaluate sleep in the intensive care unit (ICU) that is both feasible for routine clinical practice and reliable does not yet exist. We characterised nocturnal ICU sleep using a commercially available activity tracker and evaluated agreement between tracker-derived sleep data and patient-perceived sleep quality.
A prospective cohort study was performed in a 40-bed ICU at a community teaching hospital. An activity tracker (Fitbit Charge 2) was applied for up to 7 ICU days in English-speaking adults with an anticipated ICU stay ≥2 days and without mechanical ventilation, sleep apnoea, delirium, continuous sedation, contact isolation or recent anaesthesia. The Richards-Campbell Sleep Questionnaire (RCSQ) was administered each morning by a trained investigator.
Available activity tracker-derived data for each ICU study night (20:00-09:00) (total sleep time (TST), number of awakenings (#AW), and time spent light sleep, deep sleep and rapid eye movement (REM) sleep) were downloaded and analysed. Across the 232 evaluated nights (76 patients), TST and RCSQ data were available for 232 (100%), #AW data for 180 (78%) and sleep stage data for 73 (31%). Agreement between TST (349±168 min) and RCSQ Score was moderate and significant (r=0.34; 95% CI 0.18 to 0.48). Agreement between #AW (median (IQR), 4 (2-9)) and RCSQ Score was negative and non-significant (r=-0.01; 95% CI -0.19 to 0.14). Agreement between time (min) spent in light (259 (182 to 328)), deep (43±29), and REM (47 (28-72)) sleep and RCSQ Score was moderate but non-significant (light (r=0.44, 95% CI -0.05 to 0.36); deep sleep (r=0.44, 95% CI -0.11 to 0.15) and REM sleep (r=0.44; 95% CI -0.21 to 0.21)).
A Fitbit Charge 2 when applied to non-intubated adults in an ICU consistently collects TST data but not #AW or sleep stage data at night. The TST moderately correlates with patient-perceived sleep quality; a correlation between either #AW or sleep stages and sleep quality was not found.
目前,在重症监护病房(ICU)中还没有一种既经济实惠又能可靠评估睡眠的定量方法,同时还适合常规临床实践。本研究旨在使用一款商业化的活动追踪器评估 ICU 夜间睡眠,并评估追踪器得出的睡眠数据与患者自我感知的睡眠质量之间的一致性。
这是一项前瞻性队列研究,在一家社区教学医院的 40 张床位的 ICU 中进行。在预计 ICU 入住时间≥2 天且无机械通气、睡眠呼吸暂停、谵妄、持续镇静、接触隔离或近期麻醉的成年英语患者中,应用活动追踪器(Fitbit Charge 2)进行了长达 7 天的 ICU 监测。每天早晨由经过培训的调查员使用 Richards-Campbell 睡眠问卷(RCSQ)进行评估。
下载并分析了每个 ICU 研究夜(20:00-09:00)(总睡眠时间(TST)、觉醒次数(#AW)以及轻睡眠、深睡眠和快速眼动(REM)睡眠时间)的可用活动追踪器数据。在 232 个评估夜(76 例患者)中,TST 和 RCSQ 数据可用于 232 个(100%),#AW 数据可用于 180 个(78%),睡眠阶段数据可用于 73 个(31%)。TST(349±168 min)与 RCSQ 评分之间的一致性中等且显著(r=0.34;95%CI 0.18 至 0.48)。#AW(中位数(IQR),4(2-9))与 RCSQ 评分之间的一致性为负且无统计学意义(r=-0.01;95%CI -0.19 至 0.14)。在轻(259(182 至 328))、深(43±29)和 REM(47(28-72))睡眠期间的时间(min)与 RCSQ 评分之间的一致性为中度但无统计学意义(轻睡眠(r=0.44,95%CI -0.05 至 0.36);深睡眠(r=0.44,95%CI -0.11 至 0.15)和 REM 睡眠(r=0.44;95%CI -0.21 至 0.21))。
在 ICU 中,当将 Fitbit Charge 2 应用于非插管的成年人时,夜间通常可收集 TST 数据,但不能收集 #AW 或睡眠阶段数据。TST 与患者自我感知的睡眠质量中度相关;但 #AW 或睡眠阶段与睡眠质量之间无相关性。